That was the week that was… Your weekly market wrap (24-28 September)


Published 02-OCT-2018 13:03 P.M.


3 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.

Click Here to View Latest Articles

There has been significant attention concerning US tariffs and forecasting the likely outcomes, however neither the Australian market nor the S&P 500 has seen any significant movement. Last week saw markets remain steady with daily volatility less than 0.5% for the XAO and less the 1% for the S&P writes Dale Gillham.

In Australia, the Materials sector (XMJ) continued to lift the Australian market higher with the sector up 3.3% over the past five days. Interestingly, the top eight shares in percentage change have all been resource companies. This strong rally comes on the back of renewed confidence in the sector. Currently, I like the sector and think there is genuine upside potential in a number of stocks.

Energy (XEJ) is another sector doing well and was up almost 4% for the week, with strong rises from Origin Energy Ltd (ASX:ORG), Santos Ltd (ASX:STO) and AGL Energy Ltd (ASX:AGL).

Conversely, the Financials sector (XFJ) was a different story altogether with all of the big 4 banks down, and the sector as a whole, down around 1.5%.

The Consumer Discretionary sector (XDJ) has also been looking worse for wear over the past month, falling 5.2%. Webjet Ltd (ASX:WEB) fell 6.48% over the past five days, while rival Flight Centre Travel Group Ltd (ASX:FLT) fell 2.38% and JB Hi-Fi Limited (ASX:JBH) returned to a familiar space as the most shorted stock on the ASX. While the sector is not currently looking too good, things could turn around quickly.

The past performance of this product is not and should not be taken as an indication of future performance. Caution should be exercised in assessing past performance. This product, like all other financial products, is subject to market forces and unpredictable events that may adversely affect future performance.

So what do we expect in the market?

It would appear much of the tariff hype has dissipated, and the Australian reporting season has now drawn to a close with no real surprises. Economic commentators are now indicating that the tariffs imposed by the US will only have a minimum effect on the countries’ economies that are being targeted.

September has largely been lacklustre where the market fell by 4% before it inched its way back up less than half of what it fell over the following three weeks. This is a sign the market is still a little cautious, although I expect this upside move to continue over the coming weeks, with the XAO possibly reaching 6,500 points before Christmas.

The question I am being asked right now is when will the Australian share market surpass its all-time high? I believe we will see this occur in the first quarter of 2019 – although for that to occur the finance and material stocks need to rise together.

Dale Gillham, Chief Analyst at Wealth Within and author of Accelerate Your Wealth

This article is General Information and contains only some information about some elements of one or more financial products. It may contain; (1) broker projections and price targets that are only estimates and may not be met, (2) historical data in terms of earnings performance and/or share trading patterns that should not be used as the basis for an investment as they may or may not be replicated. Those considering engaging with any financial product mentioned in this article should always seek independent financial advice from a licensed financial advisor before making any financial decisions.

General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.


Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free